At a glance
ClinicalIndex Comparison RecordPhase 3Completed
Drug / intervention
magnesiumdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Magnesium in Coronaries (MAGIC)
National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Apr 14, 2016
In Brief
A Phase 3 clinical trial evaluating magnesium for Cardiovascular Diseases and 4 related conditions. Completed.
Detailed Summary
To determine whether early intravenous magnesium treatment of patients with suspected acute myocardial infarction reduces mortality.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial Infarction, Myocardial Ischemia
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 1998
First PostedOct 1999
Study CompletionNov 2003
TodayJul 2026
First PostedOct 28, 1999
Enrollment StartApr 1, 1998
Study CompletionNov 1, 2003
TodayJul 2, 2026
Posted 26.7 years ago
Interventions
magnesiumdrug